Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Clinical trial NCT04994483 · COMPLETED

Trial details

NCT number: NCT04994483
Sponsor: Cassava Sciences, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-11-03
Primary completion: 2024-10-02
Enrollment: 804

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.